Dr. Frank Silvestry, MD

Dr. Silvestry practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Silvestry's NPI, 1548346364, was assigned on October 27, 2006. Dr. Silvestry graduated from Perelman School of Med at the University of Pennsylvania in 1990. Dr. Silvestry holds Pennsylvania license MD049541L.

Dr. Silvestry's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Dr. Silvestry's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Silvestry is also affiliated with Penn Presbyterian Medical Center. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Silvestry to 3 more hospitals and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Silvestry practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Silvestry's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Silvestry is licensed in Pennsylvania.

CMS data shows 2,930 Medicare services from Dr. Silvestry across 16 procedure codes in 2024, for 845 Medicare patients. Medicare paid $102,742 for them.

CMS counts 845 Medicare patients who saw Dr. Silvestry in 2024. The largest group is 75 to 84, with 337 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Silvestry's median patient age at 71, with 45% women.

In 2024, Dr. Silvestry wrote 4,115 Medicare Part D claims for 448 patients. 82% of them were for generic drugs. CMS names the drug for 3,746 of them, across 50 drugs with 11 or more claims each, at $684,291 in total drug cost. In 2023, CMS named 3,806 claims across 46 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Silvestry for performance year 2024, reported as part of a group. Dr. Silvestry accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 35 papers to Dr. Silvestry, published from 2007 to 2024. 2019 was the busiest year, with 3. The most frequent topics are Cardiac Catheterization, Heart Failure and Atrial Fibrillation. Dr. Silvestry has published most often in Circulation. Dr. Silvestry's most frequent co-authors are Sanjiv J. Shah, MD, Howard C. Herrmann, MD and Barry A. Borlaug, MD.

Dmand AI links Dr. Silvestry to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Mitral Valve Insufficiency, Gastroesophageal Reflux and Heart Valve Diseases. Edwards Lifesciences sponsors the most, 2.

CMS Open Payments shows 59 general payments to Dr. Silvestry from 9 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 61% of the total. Edwards Lifesciences Corporation paid the most, $3,128.

Dr. Silvestry graduated from Perelman School of Med at the University of Pennsylvania in 1990.